{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:21Z","timestamp":1788872421836,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jns.2014.06.041","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T05:35:48Z","timestamp":1403847348000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Retrospective study of a TTR FAP cohort to modify NIS + 7 for therapeutic trials"],"prefix":"10.1016","volume":"344","author":[{"given":"N.","family":"Suanprasert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.B.","family":"Dyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Gollob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.R.","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Karsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Dyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2014.06.041_bb0005","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2014.06.041_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.amjcard.2011.03.040","article-title":"Rate of progression of transthyretin amyloidosis","volume":"108","author":"Benson","year":"2011","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.jns.2014.06.041_bb0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp-2011-301299","article-title":"Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas","volume":"83","author":"Koike","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.jns.2014.06.041_bb0020","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archneur.62.7.1057","article-title":"Transthyretin-related familial amyloidotic polyneuropathy","volume":"62","author":"Ando","year":"2005","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.jns.2014.06.041_bb0025","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plante-Bordeneuve","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2014.06.041_bb0030","series-title":"Amyloid and amyloidosis","first-page":"88","article-title":"Forty years of experience with type 1 amyloid neuropathy: review of 483 cases","author":"Coutinho","year":"1980"},{"issue":"Pt 7","key":"10.1016\/j.jns.2014.06.041_bb0035","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/brain\/123.7.1495","article-title":"The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation","volume":"123","author":"Adams","year":"2000","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2014.06.041_bb0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.TP.0000092307.98347.CB","article-title":"Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry","volume":"77","author":"Herlenius","year":"2004","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.jns.2014.06.041_bb0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/13506120500363609","article-title":"Early liver transplantation improves familial amyloidotic polyneuropathy patients' survival","volume":"12","author":"Suhr","year":"2005","journal-title":"Amyloid"},{"issue":"8","key":"10.1016\/j.jns.2014.06.041_bb0050","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jns.2014.06.041_bb0055","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1007\/s00415-013-7051-7","article-title":"Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy","volume":"260","author":"Coelho","year":"2013","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.jns.2014.06.041_bb0060","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s12265-013-9512-x","article-title":"Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis","volume":"6","author":"Merlini","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"issue":"24","key":"10.1016\/j.jns.2014.06.041_bb0065","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2014.06.041_bb0070","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.410380323","article-title":"Diabetic polyneuropathy in controlled clinical trials: consensus report of the peripheral nerve society","volume":"38","year":"1995","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.jns.2014.06.041_bb0075","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/jnnp.2006.093781","article-title":"Polyneuropathy dysfunction scores","volume":"77","author":"Dyck","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2014.06.041_bb0080","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1212\/WNL.45.6.1115","article-title":"Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects (RDNS-HS)","volume":"45","author":"Dyck","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.06.041_bb0085","series-title":"Peripheral neuropathy","first-page":"1063","article-title":"Quantitative sensation testing","author":"Dyck","year":"2005"},{"issue":"1","key":"10.1016\/j.jns.2014.06.041_bb0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00004691-199301000-00003","article-title":"Autonomic nervous system function","volume":"10","author":"Low","year":"1993","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.jns.2014.06.041_bb0095","series-title":"Clinical autonomic disorders","first-page":"179","article-title":"Laboratory evaluation of autonomic function","author":"Low","year":"1997"},{"key":"10.1016\/j.jns.2014.06.041_bb0100","series-title":"Peripheral neuropathy","first-page":"1103","article-title":"Quantitation of autonomic impairment","author":"Low","year":"2005"},{"key":"10.1016\/j.jns.2014.06.041_bb0105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.21332","article-title":"Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy","volume":"40","author":"Kim","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2014.06.041_bb0110","series-title":"Peripheral neuropathy","first-page":"1031","article-title":"Quantitating overall neuropathic symptoms, impairments, and outcomes","author":"Dyck","year":"2005"},{"key":"10.1016\/j.jns.2014.06.041_bb0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.49.1.229","article-title":"Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort","volume":"49","author":"Dyck","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2014.06.041_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mus.10320","article-title":"Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment","volume":"27","author":"Dyck","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2014.06.041_bb0125","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.2337\/db13-0352","article-title":"Assessing decreased sensation and increased sensory phenomena in diabetic polyneuropathies","volume":"62","author":"Dyck","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jns.2014.06.041_bb0130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/mus.23982","article-title":"Multicenter trial of the proficiency of smart quantitative sensation tests","volume":"49","author":"Dyck","year":"2014","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.jns.2014.06.041_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-510X(99)00231-2","article-title":"Outcome of liver transplantation for transthyretin amyloidosis: follow-up of Japanese familial amyloidotic polyneuropathy patients","volume":"171","author":"Tashima","year":"1999","journal-title":"J Neurol Sci"},{"issue":"9","key":"10.1016\/j.jns.2014.06.041_bb0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/WNL.0b013e318248df18","article-title":"Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy","volume":"78","author":"Yamashita","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jns.2014.06.041_bb0145","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2337\/dc11-0503","article-title":"Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4years in diabetic polyneuropathy: the NATHAN 1 trial","volume":"34","author":"Ziegler","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2014.06.041_bb0150","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/WNL.31.6.730","article-title":"Disulfiram neuropathy","volume":"31","author":"Mokri","year":"1981","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2014.06.041_bb0155","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1212\/01.WNL.0000156517.00615.A3","article-title":"Reliability and validity of the CMT neuropathy score as a measure of disability","volume":"64","author":"Shy","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2014.06.041_bb0160","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/01.wnl.0000297553.36441.ce","article-title":"Neuropathy progression in Charcot\u2013Marie\u2013Tooth disease type 1A","volume":"70","author":"Shy","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2014.06.041_bb0165","first-page":"208","article-title":"The acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy","volume":"13","author":"Harbo","year":"2008","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.jns.2014.06.041_bb0170","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/WNL.0b013e3182494d66","article-title":"Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"78","author":"Figueroa","year":"2012","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2014.06.041_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/13506129.2012.673140","article-title":"Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy","volume":"19","author":"Ackermann","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jns.2014.06.041_bb0180","series-title":"Oligonucleotide therapeutics","article-title":"Development of RNAi therapeutics","author":"Akinc","year":"2014"},{"key":"10.1016\/j.jns.2014.06.041_bb0185","series-title":"Companion to peripheral neuropathy illustrated cases and new developments","first-page":"331","article-title":"Thermal disk quantitative sensation testing of cooling discrimination","author":"Dyck","year":"2010"},{"key":"10.1016\/j.jns.2014.06.041_bb0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.21661","article-title":"Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial","volume":"42","author":"Dyck","year":"2010","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.jns.2014.06.041_bb0195","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archneurol.2012.1481","article-title":"\u201cUnequivocally abnormal\u201d vs. \u201cusual\u201d signs and symptoms for proficient diagnosis of diabetic polyneuropathy Cl vs. N Phys trial","volume":"69","author":"Dyck","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2014.06.041_bb0200","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/mus.23765","article-title":"A trial of proficiency of nerve conduction: greater standardization still needed","volume":"48","author":"Dyck","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2014.06.041_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/mus.24243","article-title":"Proficiency of nerve conduction using standard methods and reference values (trial 4)","author":"Litchy","year":"2014","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.jns.2014.06.041_bb0210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/ana.410300614","article-title":"Inter- and intra-examiner reliability of nerve conduction measurements in normal subjects","volume":"30","author":"Chaudhry","year":"1991","journal-title":"Ann Neurol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14004110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14004110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:43:02Z","timestamp":1758382982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X14004110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0022510X14004110"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.06.041","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.06.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}